2.Mucoceles and mucocele-like lesions of breast.
Chinese Journal of Pathology 2009;38(9):633-636
Adenocarcinoma, Mucinous
;
pathology
;
Breast
;
pathology
;
Breast Diseases
;
pathology
;
Breast Neoplasms
;
pathology
;
Carcinoma, Papillary
;
pathology
;
Carcinoma, Signet Ring Cell
;
pathology
;
Cystadenocarcinoma, Mucinous
;
pathology
;
Diagnosis, Differential
;
Female
;
Fibroadenoma
;
pathology
;
Fibrosarcoma
;
pathology
;
Humans
;
Mucocele
;
pathology
;
Myxosarcoma
;
pathology
3.Research progress on indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Ting WANG ; Hui WEN ; Hua-qing CUI ; Da-li YIN
Acta Pharmaceutica Sinica 2021;56(3):723-733
Indoleamine 2,3-dioxygenase 1 (IDO1) is the rate-limiting enzyme in the degradation of tryptophan to kynurenine. IDO1 is highly expressed in some tumor tissues. IDO1 can deplete tryptophan in tumor microenvironment, inhibit T cell function, and mediate the immune escape of tumor cells. Thus, IDO1 is considered a potential target of tumor immunotherapy. Currently, there are several IDO1 inhibitors in clinical research studies. The mechanism of IDO1-mediated tumor immune escape and the structure of IDO1 inhibitors are summarized in this review.
4.Rehabilitation of diabetic peripheral neuropathy with integrated traditional Chinese medicine therapy
Li-wen PIAO ; De-jian LIU ; Hong-da XU
Chinese Journal of Rehabilitation Theory and Practice 2004;10(5):309-310
ObjectiveTo observe the effect of integrated traditional Chinese medicine therapy on diabetic peripheral neuropathy.Methods22 patients with diabetic peripheral neuropathy were as the group of integrated traditional Chinese medicine therapy ,who received Chinese herbal medicine treatment(orally),acupuncture,etc. Other 20 cases were as the control group,disease natural course. The effect of two groups were compared with the means.ResultsThe patients in group of integrated traditional Chinese medicine therapy got obviously better results than that of the control group(P<0.05).ConclusionThe integrated traditional Chinese medicine therapy is effective on diabetic peripheral neuropathy.
5.Pharmacokinetics of deflazacort tablets in healthy Chinese volunteers.
Wen DING ; Li DING ; Wen-Bo LI ; Hong PAN ; Hong-Da LIN
Acta Pharmaceutica Sinica 2014;49(6):921-926
Deflazacort (DFZ, a prodrug) is well absorbed and rapidly metabolized into the active metabolite 21-hydroxydeflazacort (21-OH DFZ) after oral administration. The aim of this study is to evaluate the pharmacokinetic properties of 21-OH DFZ in healthy Chinese volunteers after a single and multiple oral administration of DFZ tablets under fed condition. Twelve volunteers (six males and six females) were administered a single dose of 6 mg or 12 mg or 24 mg of DFZ in three different periods separately, according to the 3 x 3 Latin square design. Between each administration period there was a washout period of one week. The multiple-dose study of 12 mg dose DFZ per day for 7 consecutive days was started after a 1 w washout period when the single-dose study completed. The pharmacokinetic parameters of 21-OH DFZ after the single oral administration of 6 mg, 12 mg and 24 mg DFZ tablets were as follows: (37.7 +/- 11.6), (61.5 +/- 17.7) and (123 +/- 23) ng x mL(-1) for C(max); (1.90 +/- 0.32), (1.96 +/- 0.27) and (2.13 +/- 0.34) h for t1/2; (96.6 +/- 25.9), (190 +/- 44) and (422 +/- 107) ng x h x mL(-1) for AUC(0-14 h), respectively. After the multiple dose administration, the mean plasma concentration at steady-state C(av) was (7.00 +/- 1.66) ng x mL(-1) and the degree of plasma concentration fluctuation DF was 7.7 +/- 1.2. The results showed that the pharmacokinetic characteristics of 21-OH DFZ in healthy Chinese volunteers were linear over the dose range of 6 to 24 mg. No significant gender differences were found in the pharmacokinetics of 21-OH DFZ in healthy Chinese volunteers. After the multiple dose administration of 12 mg DFZ for 7 d, no accumulation of 21-OH DFZ in healthy Chinese volunteers was observed.
Administration, Oral
;
Area Under Curve
;
Asian Continental Ancestry Group
;
Female
;
Healthy Volunteers
;
Humans
;
Male
;
Pregnenediones
;
pharmacokinetics
;
Tablets
6.Detection the serum IgM and IgG specific for TORCH in 1307 women in the period of pre-pregnancy and pregnancy.
Wen QIN ; Da-chun HU ; Hai-li PANG
Chinese Journal of Experimental and Clinical Virology 2011;25(4):292-294
OBJECTIVEThe objective is to obtain the information of women in the period of prepregnancy and pregnancy infected by TORCH (Toxoplasma, Rabella Virus, Cytomegalovirus, and Herpes Simplex Virus) in Kunming for preventing fetus from infection by TORCH in uterus.
METHODSThe serum IgM and IgG specific for TORCH from 1307 women in the period of pre-pregnancy and pregnancy were measured with ELISA and The reagent is the product of virion/serion.
RESULTSThe serum IgM specific for TORCH were detected in 2.83% of 1307 pregnant women for Toxoplasma, 2.37% for Rebulla Virus, 0.46% for Cytomegalovirus, 2.45% for Herpes Simplex Virus. The total positive rate of serum IgM specific for TORCH was 1.45%. The serum IgG specific for TORCH were detected in 3.98% of 1307 pregnant women for Toxoplasma, 72.3% for Rebulla Virus, 97.78% for Cytomegalovirus, 80.34% for Herpes Simplex Virus. The total positive rate of serum IgG specific for TORCH was 63.60%. There was no significant difference among the women with different pregnant situation in terms of the serum IgM and IgG specific for TORCH.
CONCLUSIONThere are some of women in the period of pre-pregnancy and pregnancy with current infection by TORCH in Kunming. It is recommended to screen for infection by TORCH in women in the period of pre-pregnancy and pregnancy to prevent fetus from infection by TORCH in uterus.
Adolescent ; Adult ; Antibodies, Protozoan ; blood ; Antibodies, Viral ; blood ; Cytomegalovirus ; immunology ; isolation & purification ; Female ; Humans ; Immunoglobulin G ; blood ; Immunoglobulin M ; blood ; Mass Screening ; Middle Aged ; Pregnancy ; Pregnancy Complications, Infectious ; immunology ; parasitology ; prevention & control ; virology ; Rubella virus ; immunology ; isolation & purification ; Simplexvirus ; immunology ; isolation & purification ; Toxoplasma ; immunology ; isolation & purification ; Women ; Young Adult
7.Surgical repair and reconstruction of male external genitals.
Zhong WANG ; Hai-jun YAO ; Da-chao ZHENG ; Wen-ji LI
National Journal of Andrology 2015;21(7):579-586
One of the challenges in andrology nowadays is the diagnosis and treatment of external genital abnormalities and defects along with the consequent voiding, sexual, and reproductive dysfunctions, for which no guidelines are yet available. Hitherto, surgical repair and reconstruction are efficient for these diseases. The key to these operations is to individualize surgical strategies according to the specific local lesion and dysfunction, usually involving flap and graft techniques. This article presents our experience in the surgical treatment of penile and scrotal abnormalities and defects with urological and andrological techniques and microsurgical strategies, focusing on the external repair and functional reconstruction. Satisfactory treatment outcomes pivot on a precise evaluation of the disease, a rational design of surgical procedures, and an earnest communication with the patient. Some cases are rather complicated and challenging, usually with complications, and therefore deserve further researches for more effective treatment strategies in clinical practice.
Andrology
;
Genitalia, Male
;
abnormalities
;
surgery
;
Humans
;
Male
;
Penis
;
abnormalities
;
surgery
;
Reconstructive Surgical Procedures
;
methods
;
Scrotum
;
abnormalities
;
surgery
;
Surgical Flaps
;
Treatment Outcome
8.Diagnosis and surgery of primary tracheal neoplasms in children.
Da-bo LIU ; Jian-wen ZHONG ; Li-feng ZHOU
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2009;44(4):337-338
Bronchoscopy
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Male
;
Retrospective Studies
;
Tracheal Neoplasms
;
diagnosis
;
surgery
9.Research and practice about risk control of shenfu injection.
Zhi-Fei WANG ; Da-Li TIAN ; Wen ZHANG ; Yan-Ming XIE
China Journal of Chinese Materia Medica 2014;39(18):3641-3644
Shenfu injection is developed by improving dosage form of ancient prescription "Shenfu Tang" and is mainly derived from extracts of both traditional Chinese medicine red ginseng and prepared lateral root of monkshood with polysorbate 80 as auxiliary material. Shenfu injection may be administered through intramuscular injection, intravenous drip or intravenous injection. It produces good effects in restoring Yang and rescuing patients from collapse, tonifying Qi and preventing exhaustion. It is mainly used to treat not only syncope and prostration resulting from sudden Yang collapse (infectious, hemorrhagic and water depletion shock etc), but also pavor, palpitation, dyspnea with cough, stomachache, diarrhea and arthralgia etc caused by deficiency of Yang (deficiency of vital energy). Research group has audited the monitored hospitals and has carried out postmarketing study of Shenfu solution from many aspects including literature review, spontaneous reporting system (SRS) and hospital information system (HIS) data analysis etc. A summary is shown below.
Drugs, Chinese Herbal
;
administration & dosage
;
adverse effects
;
Humans
;
Injections
;
Medicine, Chinese Traditional
;
methods
10.Value of urinary retinal binding protein in early renal function impairment for patients with pneumoconiosis complicated with chronic obstructive pulmonary diseases.
Jun-he DAI ; Si-hai LIU ; Xiao-jing LIU ; Li-da YAN ; Wen-shou XU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2006;24(2):123-124